Work

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps9107

Authors: Hector J. Soto Parra, Laura Noto, Domenico Galetta, Francesco Ferraú, Vittorio Gebbia, Pierfrancesco Tassone, Francesco Verderame, Marco M. Aiello, Fiorenza Latteri, Silvia Novello

Institutions: Policlinico Universitario di Catania, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Istituto Tumori Bari, La Maddalena, Magna Graecia University, Ospedale Vincenzo Cervello, University of Turin

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4243023366

Cites:

Cited by: 3

Related to: 10